You searched for "blind"
Evaluation of the association between diabetes autoantibodies and development of early diabetic retinopathy in type 1 diabetes
This study was conducted to investigate the relationship between diabetes autoantibodies and the development of early diabetic retinopathy (DR) to assess the role of autoimmunity in retinopathy. The study included 18 boys and 44 girls with type 1 diabetes mellitus...
Canadian centre experience with ocular cystinosis cases
Ocular cystinosis (OC) is an uncommon recessive genetic disease occurring in about one case per 100–200,000 live births. Patients have accumulation of cystine crystals within tissues. Ocular symptoms include photophobia, blepharospasm, foreign body sensation, retinopathy and visual impairment. Crystals have...
Hypothesis for poor visual outcomes in myeline oligodendrocyte glycoprotein-related optic neuritis after first attack
The authors present a retrospective case review with the aim of describing the group of patients with myelin-oligodendrocyte glycoprotein-associated optic neuritis (MOG-ON) who had poor visual outcomes following their first attack despite rapid treatment. The study was conducted at a...
High prevalence of strabismus and variable surgical success in children with developmental delay
On the basis of lack of consensus for the treatment of strabismus in children with developmental delay, the authors reviewed the literature to provide information on the topic and present results from their clinical experience. From the review, they include...Glaukos at ESCRS 2025
The 2026 ESCRS meeting in Copenhagen was a highly successful and busy event for Glaukos, highlighted by the launch of iStent infinite®. The new device was prominently featured across podium presentations, booth speaker sessions, and hands-on dry labs, following its...Raphaél Ervinckx joins Glaukos
Glaukos Corporation has appointed Raphaél Ervinckx as Vice President and General Manager for the EMEAI region, marking a strategic move to support the company’s continued international growth. Raphaël Ervinckx brings extensive experience in the ophthalmology sector, most recently serving as...Graham Popham joins Glaukos as Senior Director, Market Access EMEAI
Glaukos are delighted to announce the appointment of Graham Popham as Senior Director, Market Access EMEAI. Graham comments: "’I'm excited to join Glaukos at such a pivotal time in the evolution of ophthalmic care and growth of the organisation. Throughout...
Outline of clinical care for healthy newborns with uncomplicated conjunctivitis in the US
The purpose of this study was to explore the current state of clinical care for healthy newborns with uncomplicated ophthalmia neonatorum (ON) using a large electronic health record dataset. Despite the existence of national guidelines for antepartum screening for N....Heidelberg Engineering joins the Collaborative Community on Ophthalmic Innovation (CCOI) through EssilorLuxottica’s Vision Architect membership
Heidelberg Engineering announced that it is joining the Collaborative Community on Ophthalmic Innovation (CCOI) as part of its parent company EssilorLuxottica’s Vision Architect membership – CCOI’s highest level of industry participation. CCOI is a public–private forum that convenes patients, clinicians,...
Prism adaptation responses for variable distance-near deviation in intermittent exotropia
The purpose of this study was to evaluate the effect of the prism adaptation test (PAT) on angle and distance-near-deviation (DND) in intermittent exotropia (IXT), and determine the frequency of responders and non-responders to PAT. This was a single-centre study...Surgitrac Instruments to Exhibit at UKISCRS Cornea & Cataract Day
Surgitrac Instruments is pleased to announce its participation in the United Kingdom & Ireland Society of Cataract and Refractive Surgeons (UKISCRS) Cornea & Cataract Day 2026, taking place on 16 March in Edinburgh. The event brings together leading ophthalmic professionals...
